Generics
DifGen Pharmaceuticals' single injection treatment for advanced breast cancer cleared for clinical development
28 July 2026 - Generic pharmaceuticals manufacturer DifGen Pharmaceuticals LLC announced on Monday that the US Food and Drug Administration (FDA) has accepted the company's Investigational New Dr...
Par Health launches generic version of Janumet XR tablets in US
27 July 2026 - US pharmaceutical company Par Health Inc announced on Friday the launch of its generic version of Merck's Janumet XR (sitagliptin and metformin HCl extended-release) tablets for or...
EQL Pharma gains approval to sell Mellozzan in Kazakhstan
15 July 2026 - Swedish pharmaceutical company EQL Pharma AB (STO: EQL), which specialises in developing and selling generics, said on Wednesday it has secured approval for its melatonin-based product ...
Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib
13 July 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Monday that it has received marketing authorisation in Sweden for Tofacitinib Newbury 5 mg and 10 mg ...
Lupin announces US launch of Azilsartan Medoxomil Tablets
18 June 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Thursday the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States fol...
Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz
5 June 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes, and sells generic medicines in the United States, announced on Thursday th...